Answers are grounded in this paper and cite their sources.
After contemporary everolimus-eluting stent implantation, women and minorities experience a similar risk of 1-year MACE but a higher adjusted risk of recurrent ischemic events primarily because of nonstent-related MIs. Both clinical and angiographic factors and social determinants of health, including widowhood and insurance status, contribute to 1-year MACE among women and minorities.
No takes yet. Share an insight, caveat, or question.
Batchelor et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: